These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 31369629)

  • 21. Effect of Education on Alzheimer's Disease-Related Neuroimaging Biomarkers in Healthy Controls, and Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Cross-Sectional Study.
    Wada M; Noda Y; Shinagawa S; Chung JK; Sawada K; Ogyu K; Tarumi R; Tsugawa S; Miyazaki T; Yamagata B; Graff-Guerrero A; Mimura M; Nakajima S;
    J Alzheimers Dis; 2018; 63(2):861-869. PubMed ID: 29689728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cortical signature of clock drawing performance in Alzheimer's disease and mild cognitive impairment.
    Hirjak D; Wolf RC; Pfeifer B; Kubera KM; Thomann AK; Seidl U; Maier-Hein KH; Schröder J; Thomann PA
    J Psychiatr Res; 2017 Jul; 90():133-142. PubMed ID: 28284155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cortical phase changes measured using 7-T MRI in subjects with subjective cognitive impairment, and their association with cognitive function.
    van Rooden S; Buijs M; van Vliet ME; Versluis MJ; Webb AG; Oleksik AM; van de Wiel L; Middelkoop HA; Blauw GJ; Weverling-Rynsburger AW; Goos JD; van der Flier WM; Koene T; Scheltens P; Barkhof F; van de Rest O; Slagboom PE; van Buchem MA; van der Grond J
    NMR Biomed; 2016 Sep; 29(9):1289-94. PubMed ID: 25522735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative study: visual rating scores and the voxel-based specific regional analysis system for Alzheimer's disease on magnetic resonance imaging among subjects with Alzheimer's disease, mild cognitive impairment, and normal cognition.
    Li F; Takechi H; Saito R; Ayaki T; Kokuryu A; Kuzuya A; Takahashi R
    Psychogeriatrics; 2019 Mar; 19(2):95-104. PubMed ID: 30276926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atrophy in Distributed Networks Predicts Cognition in Alzheimer's Disease and Type 2 Diabetes.
    Buss SS; Padmanabhan J; Saxena S; Pascual-Leone A; Fried PJ
    J Alzheimers Dis; 2018; 65(4):1301-1312. PubMed ID: 30149455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease.
    Croteau E; Castellano CA; Fortier M; Bocti C; Fulop T; Paquet N; Cunnane SC
    Exp Gerontol; 2018 Jul; 107():18-26. PubMed ID: 28709938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution of Cortical Atrophy Associated with Cognitive Decline in Alzheimer's Disease: A Cross-Sectional Quantitative Structural MRI Study from PUMCH Dementia Cohort.
    Mao C; Hou B; Li J; Chu S; Huang X; Wang J; Dong L; Liu C; Feng F; Peng B; Gao J
    Curr Alzheimer Res; 2022; 19(8):618-627. PubMed ID: 36065913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An MRI brain atrophy and lesion index to assess the progression of structural changes in Alzheimer's disease, mild cognitive impairment, and normal aging: a follow-up study.
    Zhang N; Song X; Zhang Y; Chen W; D'Arcy RC; Darvesh S; Fisk JD; Rockwood K;
    J Alzheimers Dis; 2011; 26 Suppl 3():359-67. PubMed ID: 21971475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A quick test of cognitive speed in older adults with Alzheimer's disease and mild cognitive impairment: A preliminary behavioral and brain imaging study.
    Park S; Pyo S; Shin SA; Lee JY; Kim YK; Park HJ; Youn JH; Park SW; Lee JY
    Psychiatry Res Neuroimaging; 2018 Oct; 280():30-38. PubMed ID: 30145383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different Cortical Gyrification Patterns in Alzheimer's Disease and Impact on Memory Performance.
    Núñez C; Callén A; Lombardini F; Compta Y; Stephan-Otto C;
    Ann Neurol; 2020 Jul; 88(1):67-80. PubMed ID: 32277502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study.
    Paajanen T; Hänninen T; Tunnard C; Hallikainen M; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H
    J Alzheimers Dis; 2014; 39(3):679-90. PubMed ID: 24246420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
    Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cortical thickness in relation to clinical symptom onset in preclinical AD.
    Pettigrew C; Soldan A; Zhu Y; Wang MC; Moghekar A; Brown T; Miller M; Albert M;
    Neuroimage Clin; 2016; 12():116-22. PubMed ID: 27408796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain volumes and cortical thickness on MRI in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER).
    Stephen R; Liu Y; Ngandu T; Antikainen R; Hulkkonen J; Koikkalainen J; Kemppainen N; Lötjönen J; Levälahti E; Parkkola R; Pippola P; Rinne J; Strandberg T; Tuomilehto J; Vanninen R; Kivipelto M; Soininen H; Solomon A;
    Alzheimers Res Ther; 2019 Jun; 11(1):53. PubMed ID: 31164160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibre-specific white matter reductions in Alzheimer's disease and mild cognitive impairment.
    Mito R; Raffelt D; Dhollander T; Vaughan DN; Tournier JD; Salvado O; Brodtmann A; Rowe CC; Villemagne VL; Connelly A
    Brain; 2018 Mar; 141(3):888-902. PubMed ID: 29309541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations of whole-brain cortical area and thickness in mild cognitive impairment and Alzheimer's disease.
    Li C; Wang J; Gui L; Zheng J; Liu C; Du H
    J Alzheimers Dis; 2011; 27(2):281-90. PubMed ID: 21799248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frontal-executive and corticolimbic structural brain circuitry in older people with remitted depression, mild cognitive impairment, Alzheimer's dementia, and normal cognition.
    Rashidi-Ranjbar N; Rajji TK; Kumar S; Herrmann N; Mah L; Flint AJ; Fischer CE; Butters MA; Pollock BG; Dickie EW; Anderson JAE; Mulsant BH; Voineskos AN
    Neuropsychopharmacology; 2020 Aug; 45(9):1567-1578. PubMed ID: 32422643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased Cortical Thickness and Local Gyrification in Individuals with Subjective Cognitive Impairment.
    Youn H; Choi M; Lee S; Kim D; Suh S; Han CE; Jeong HG
    Clin Psychopharmacol Neurosci; 2021 Nov; 19(4):640-652. PubMed ID: 34690119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrophy subtypes in prodromal Alzheimer's disease are associated with cognitive decline.
    Ten Kate M; Dicks E; Visser PJ; van der Flier WM; Teunissen CE; Barkhof F; Scheltens P; Tijms BM;
    Brain; 2018 Dec; 141(12):3443-3456. PubMed ID: 30351346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.